Open Access

Searching for the methylation sites involved in human papillomavirus type 16 and 18‑positive women with cervical cancer

  • Authors:
    • Yanyun Ma
    • Chunxia Wang
    • Mengqi Shi
    • Mingshan Li
    • Lin Li
    • Tuanjie Che
    • Jing Qu
  • View Affiliations

  • Published online on: September 2, 2022     https://doi.org/10.3892/mco.2022.2582
  • Article Number: 149
  • Copyright: © Ma et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

It has been reported that >90% of women with cervical cancer are human papillomavirus (HPV)‑positive, with HPV16 and 18 being the most ‘highest‑risk’ HPV genotypes. However, in numerous women, HPV infection will not progress to cervical cancer. Accordingly, more appropriate screening markers need to be explored. In the present study, genome‑wide DNA methylomic differences between cervical cancer tissues with HPV‑16 or HPV‑18 infection and normal cervical tissues were detected by using an Illumina Human Methylation 850 K BeadChip. The Gene Ontology functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were conducted in order to define the nearest neighbouring genes of differentiated methylation sites. Moreover, differentiated methylation sites were verified using pyrosequencing. KEGG analyses suggested that the focal adhesion pathway and pathways in cancer were highly enriched. Bioinformatics and statistical analysis indicated that the nine CpG loci had the most significant differences amongst the genes involved in these pathways. Among these, six CpG sites in the CHRM2, LAMA4, COL11A1, FGF10, IGF1 and TEK genes were highly associated with HPV‑16‑positive cervical cancer, as validated using pyrophosphate sequencing. Additionally, 10 significantly different CpG sites of the HPV‑18‑positive group were selected and verified in The Cancer Genome Atlas, indicating their possible diagnostic roles in cervical cancer development and determination. In addition, eight hypermethylated CpG island sites that were associated with HPV‑16‑positive cervical cancer tissues and 10 hypermethylated CpG island sites that were associated with HPV‑18‑positive cervical cancer tissues were identified, highlighting their potential roles in screening and evaluating targeted therapy efficacy and prognosis. The main focus of the present study was to identify the genetic variability in HPV‑16‑ and HPV‑18‑positive samples and to elucidate possible methylation biomarkers in HPV‑positive women with a risk of developing cervical cancer.

Related Articles

Journal Cover

October-2022
Volume 17 Issue 4

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ma Y, Wang C, Shi M, Li M, Li L, Che T and Qu J: Searching for the methylation sites involved in human papillomavirus type 16 and 18‑positive women with cervical cancer. Mol Clin Oncol 17: 149, 2022
APA
Ma, Y., Wang, C., Shi, M., Li, M., Li, L., Che, T., & Qu, J. (2022). Searching for the methylation sites involved in human papillomavirus type 16 and 18‑positive women with cervical cancer. Molecular and Clinical Oncology, 17, 149. https://doi.org/10.3892/mco.2022.2582
MLA
Ma, Y., Wang, C., Shi, M., Li, M., Li, L., Che, T., Qu, J."Searching for the methylation sites involved in human papillomavirus type 16 and 18‑positive women with cervical cancer". Molecular and Clinical Oncology 17.4 (2022): 149.
Chicago
Ma, Y., Wang, C., Shi, M., Li, M., Li, L., Che, T., Qu, J."Searching for the methylation sites involved in human papillomavirus type 16 and 18‑positive women with cervical cancer". Molecular and Clinical Oncology 17, no. 4 (2022): 149. https://doi.org/10.3892/mco.2022.2582